https://www.zacks.com/stock/news/2260545/ge-healthcare-s-gehc-new-tie-up-to-boost-patient-outcomes?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2260545
Apr 23, 2024 - GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.
zc:1224571644777103906
0
https://www.zacks.com/stock/news/2262672/newmont-s-nem-q1-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2262672
Apr 25, 2024 - Newmont's (NEM) first-quarter earnings and revenues exceed expectations, driven by increased production and higher realized gold prices.
zc:-4627434763694045328
0
https://www.zacks.com/stock/news/2262625/revvity-s-rvty-new-launch-to-boost-tuberculosis-testing?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2262625
Apr 25, 2024 - Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
zc:-2268812784153408101
0
https://www.zacks.com/stock/news/2263531/agnico-eagle-s-aem-q1-earnings-and-sales-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2263531
Apr 26, 2024 - Agnico Eagle's (AEM) first-quarter earnings and revenues exceed expectations, driven by increased production and higher realized gold prices.
zc:-5223852078717817835
0
https://www.zacks.com/stock/news/2263587/factors-setting-the-tone-for-ecolab-s-ecl-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263587
Apr 26, 2024 - Ecolab's (ECL) first-quarter results are likely to reflect continued segmental strength.
zc:-5620118755918746176
0
https://www.zacks.com/stock/news/2259379/3-dividend-aristocrats-to-take-the-edge-off-market-volatility?cid=CS-ZC-FT-analyst_blog|investment_ideas-2259379
Apr 22, 2024 - With markets remaining topsy-turvy, it's prudent for astute investors to pick dividend aristocrats like Atmos Energy (ATO), Ecolab (ECL) and SherwinWilliams (SHW) for steady income.
zc:8120346118959775551
0
https://www.zacks.com/stock/news/2260548/reasons-why-you-should-retain-healthequity-hqy-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2260548
Apr 23, 2024 - HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
zc:-3338203643352406791
0
https://www.zacks.com/stock/news/2261445/penumbra-s-pen-new-launch-to-enhance-blood-clot-removal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2261445
Apr 24, 2024 - Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
zc:3412816227384266707
0